Convexia Analysis: $500K Raised
What is Convexia?
Convexia is an AI-maximalist pharma company focused on uncovering overlooked drug assets. Their approach integrates specialized AI agents with expert human review, streamlining the drug development process. This enables faster identification and evaluation of high-potential therapeutics, transforming traditional drug sourcing methods.
Location
San Francisco, United States
Employees
1-10
Founded
2025
Industry
AI/ML, HealthTech, Biotech
Funding Category 1
Seed
Latest Funding Amount
$500,000
Total Money Raised
$500,000
Product Features & Capabilities
- Asset Discovery Agent for global drug asset scanning
- Scientific Evaluation Stack with over 50 custom models
- Specialist Human Review by domain experts
- Market Insight Agent for competitive analysis
- Operational Risk Agent for trial risk assessment.
How much Convexia raised
Unknown - $500,000
Other Considerations
Backed by Stanford and Y Combinator; Collaborates with CROs for clinical trials; Focuses on AI-driven drug lifecycle management.
